Qualigen Therapeutics Inc (QLGN): Does that mean that there will be plenty...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	10
Posts	594
Boards Moderated	0
Alias Born	10/21/2013

Sprincenatu

Re: Sprincenatu post# 78

Monday, 11/29/2021 4:17:08 PM

Monday, November 29, 2021 4:17:08 PM

Does that mean that there will be plenty of shares available at a price around $1.50 in 2 days?

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent QLGN News

Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 09:15:12 PM
Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN) • GlobeNewswire Inc. • 09/06/2024 09:00:00 PM
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering • GlobeNewswire Inc. • 09/06/2024 08:30:00 PM
Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/06/2024 07:46:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 01:25:32 PM
Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering • GlobeNewswire Inc. • 09/05/2024 01:00:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/05/2024 04:15:03 AM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/22/2024 08:41:06 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:06:05 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/09/2024 07:58:55 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/07/2024 09:28:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 08:10:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 09:00:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 09:06:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 10:15:32 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 09:25:27 PM
Lifecore Biomedical Announces Cooperation Agreement with 22NW • GlobeNewswire Inc. • 07/01/2024 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:00:18 PM
Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination • GlobeNewswire Inc. • 05/30/2024 08:00:00 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/14/2024 08:05:19 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/04/2024 12:59:19 AM
Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™ • GlobeNewswire Inc. • 04/16/2024 11:00:00 AM

More QLGN News

InvestorsHub NewsWire

FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM

Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM

PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM

North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM

One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM

Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover